FDA Holds Up Edwards-DexCom Continuous Glucose Monitor For Hospital Use

Edwards Lifesciences' and DexComs’ first-of-its-kind continuous glucose monitor for hospital use is running into delays at FDA.

More from Archive

More from Medtech Insight